ESCMID Publications

ESCMID Panorama

Guidelines written or endorsed by ESCMID

Current ESCMID Guidelines Director:
Professor William W. Hope, Liverpool, UK

Contact through ESCMID office

 

These Guidelines are provided for personal use only, and not for distribution or commercial re-use.

10 May 2017

Update on the medical guideline "Diagnosis and management of Aspergillus disease" - in publication process

The draft guideline was under public consultation from 28 March to 09 May 2017.

Once the current manuscript is published, it will appear here along with the comments from the public consultation phase and the author's responses to them.

This guideline is coordinated by the ESCMID Fungal Infection Study Group (EFISG)

28 March 2017

Guideline on the diagnosis and management of Aspergillus disease open for public consultation

The draft version of the medical guideline on the diagnosis and treatment of Aspergillus disease has now entered into the public consultation phase. The guideline is a result of the concerted efforts of ESCMID, through its fungal infections study group (EFISG), the European Confederation of Medical Mycology (ECMM) and the European Respiratory Society (ERS).

 

Those of you wishing to comment on the manuscript may write to the ESCMID Publications and Medical Guidelines Manager to request the (confidential) draft of the manuscript along with the comments form for listing feedback. We are happy to receive your feedback and comments on the manuscript until 09 May 2017. Please be aware that your comments and the authors’ responses to the comments will be made available online once the guideline is published.

15 March 2017

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2016

Crit Care Med. 2017 Mar;45(3):486-552

Intensive Care Med. 2017 Mar;43(3):304-377

ESCMID endorses this guideline.

This guideline came together by the concerted effort of 55 international experts, divided into 5 groups. Each group addressed one of the following topics: hemodynamics, infection, adjunctive therapies, metabolism, and ventilation. The resulting document contains 93 statements on early management and resuscitation of patients with sepsis or septic shock, 32 strong recommendations, 39 weak recommendations and 18 best-practice statements.

Of note, in this version, information on the management of pediatric SSC patients was omitted. This matter will be discussed in a separate publication by the SCCM and the ESICM.

Clin Microbiol Infect 2016; 22 (Suppl. 4)

Published guideline (published online: 22 July 2016)

This guideline was coordinated by the ESCMID Study Group for Clostridium difficile (ESGCD)

Guideline development history:

Clin Microbiol Infect 2016; 22 (Suppl. 3)

Published guideline (published online: 7 April 2016)

This guideline was coordinated by the ESCMID Study Group for Infections of the Brain (ESGIB)

Guideline development history:

The world’s first guidelines for chronic fungal lung infections for doctors and laboratories have been published by the European Respiratory Society (ERS) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Published in the European Respiratory Journal, these new guidelines describe the important features of this disease and provide comprehensive treatment recommendations.

15 September 2015

Update of the diagnostic guidance document for Clostridium difficile infection - in publication process

The draft guideline was under public consultation (11 August - 14 September 2015). Once the guideline article is published, it will appear here along with the comments from public consultation and the authors' responses to them.

This guideline is coordinated by the ESCMID Study Group for Clostridium difficile (ESGCD)

15 September 2015

Diagnosis and treatment of acute bacterial meningitis - in publication process

The draft guideline was under public consultation (11 August - 14 September 2015). Once the guideline article is published, it will appear here along with the comments from public consultation and the authors' responses to them.

This guideline is coordinated by the ESCMID Study Group for Infections of the Brain (ESGIB)

Clin Microbiol Infect 2015; 21 (Suppl. 1)

Coordinated by the ESCMID Study Group for Biofilms (ESGB)

ESCMID and ECMM guidelines for the management of rare and emerging fungal infections

Clin Microbiol Infect 2014; 20 (Suppl. 3)

Coordinated by the ESCMID Fungal Infection Study Group (EFISG)

Editorial

O. A. Cornely et al.

Pages 1-4

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013

O. A. Cornely et al.

Pages 5-26

ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

A. M. Tortorano et al.

Pages 27-46

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

A. Chowdhary et al.

Pages 47-75

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

M. C. Arendrup et al.

Pages 76-98

Clin Microbiol Infect 2014; Vol 20 (Suppl s2), pp 1–26

The previous European Society of Clinical Microbiology and Infection (ESCMID) guidance document, which has been applied widely in clinical practice, dates from 2009. Meanwhile, new treatments for Clostridium difficile infection (CDI) have been developed and limitations of the currently recommended treatment options of CDI are considered. As the current ESCMID treatment guidance document is already implemented in clinical practice, an update of this widely applied guidance document is essential to further improve uniformity of national hospital infection treatment policies for CDI in Europe.

Clin Microbiol Infect 2014; Vol 20 (Suppl s1), pp 1–55

Healthcare-associated infections due to multidrug-resistant Gram-negative bacteria (MDR-GNB) are a leading cause of morbidity and mortality worldwide. These evidence-based guidelines have been produced after a systematic review of published studies on infection prevention and control interventions aimed at reducing the transmission of MDR-GNB. The recommendations are stratified by type of infection prevention and control intervention and species of MDR-GNB and are presented in the form of ‘basic’ practices, recommended for all acute care facilities, and ‘additional special approaches’ to be considered when there is still clinical and/or epidemiological and/or molecular evidence of ongoing transmission, despite the application of the basic measures. The level of evidence for and strength of each recommendation, were defined according to the GRADE approach.

Guidelines for antibacterial treatment in haematology patients

Editorial: The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients

Inge C. Gyssens, Winfried V. Kern and David M. Livermore on behalf of ECIL-4, a joint venture of EBMT, EORTC, ICHS and ESGICH of ESCMID

haematol December 1, 2013 vol. 98 no. 12 1821-1825

European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia

Diana Averbuch, Christina Orasch, Catherine Cordonnier, David M. Livermore, Małgorzata Mikulska, Claudio Viscoli, Inge C. Gyssens, Winfried V. Kern, Galina Klyasova, Oscar Marchetti, Dan Engelhard and Murat Akova on behalf of ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN

haematol December 1, 2013 vol. 98 no. 12 1826-1835

Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)

Diana Averbuch, Catherine Cordonnier, David M. Livermore, Małgorzata Mikulska, Christina Orasch, Claudio Viscoli, Inge C. Gyssens, Winfried V. Kern, Galina Klyasova, Oscar Marchetti, Dan Engelhard and Murat Akova on behalf of ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN

haematol December 1, 2013 vol. 98 no. 12 1836-1847

Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients

Malgorzata Mikulska, Claudio Viscoli, Christina Orasch, David M. Livermore, Diana Averbuch, Catherine Cordonnier, Murat Akova, the Fourth European Conference on Infections in Leukemia Group (ECIL-4), a joint venture of EBMT, EORTC, ICHS, ELN and ESGICH/ESCMID

J. Infect. 2013
doi:10.1016/j.jinf.2013.12.006, accepted 8 December 2013, published online 26 December 2013.

Written by the HIV in Europe initiative that is directed by an independent group of experts which has come together to work for optimal testing and earlier care for HIV in Europe. ESCMID endorses this guidance.

The objectives of the guidance are to:

  • Encourage and support the inclusion of indicator condition-guided HIV testing in national HIV testing strategies, taking into account the local HIV prevalence, ongoing testing programmes and the local healthcare setting;
  • Recommend approaches and practical tools for education and training of healthcare professionals on overcoming barriers to recommending an HIV test.

[Picture © HIV in Europe: HIV Indicator Conditions: Guidance for Implementing HIV Testing in Adults in Health Care Settings]

 

Full text

HIV in Europe initiative website

Crit Care Med. 2013 Feb;41(2):580-637.

ESCMID endorses this guidance.

Strong agreement existed among a large cohort of international experts regarding many level 1 recommendations for the best care of patients with severe sepsis. Although a significant number of aspects of care have relatively weak support, evidence-based recommendations regarding the acute management of sepsis and septic shock are the foundation of improved outcomes for this important group of critically ill patients.

ESCMID guideline for the diagnosis and management of Candida diseases 2012

Clin Microbiol Infect 2012; 18 (Suppl. 7)

Coordinated by the ESCMID Fungal Infection Study Group (EFISG)

Developing European guidelines in clinical microbiology and infectious diseases

A. J. Ullmann et al.

Pages 1-8

Diagnostic procedures

M. Cuenca-Estrella et al.

Pages 9-18

Non-neutropenic adult patients

O. A. Cornely et al.

Pages 19-37

Prevention and management of invasive infections in neonates and children caused by Candida spp.

W. W. Hope et al.

Pages 38-52

Adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

A. J. Ullmann et al.

Pages 53-67

Patients with HIV infection or AIDS

O. Lortholary et al.

Pages 68-77

ESCMID Sore Throat Guideline Group

C. Pelucchi, L. Grigoryan, C. Galeone, S. Esposito, P. Huovinen, P. Little and T. Verheij. Clin Microbiol Infect 2012; 18 (Suppl. 1): 1–27

Full text

M. Woodhead, F. Blasi, S. Ewig, J. Garau, G. Huchon, M. Ieven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, R. Read and T. J. M. Verheij. Clinical Microbiology and Infection 2011; 17(Suppl. 6): 1-24 & E1–E59

Executive Summary /  Full text

Kalpana Gupta, Thomas M. Hooton, Kurt G. Naber, Bjorn Wullt, Richard Colgan, Loren G. Miller, Gregory J. Moran, Lindsay E. Nicolle, Raul Raz, Anthony J. Schaeffer, and David E. Soper. Clinical Infectious Diseases 2011; 52: 103-120

Executive Summary /  Full text

Thomas M. Hooton, Suzanne F. Bradley, Diana D. Cardenas, Richard Colgan, Suzanne E. Geerlings, James C. Rice, Sanjay Saint, Anthony J. Schaeffer, Paul A. Tambayh, Peter Tenke, and Lindsay E. Nicolle, Clinical Infectious Diseases 2010; 50: 625-663

M. P. Bauer, E. J. Kuijper and J. T. van Dissel, Clin Microbiol Infect 2009; 15: 1067–1079

M. J. T. Crobach, O. M. Dekkers, M. H. Wilcox and E. J. Kuijper, Clin Microbiol Infect 2009; 15: 1053–1066

Torres A, Ewig S, Lode H, Carlet J, for the European HAP Working Group. Intensive Care Medicine 2009; 35: 1336-9.
Under the auspices of the European Respiratory Society (ERS), ESCMID and the European Society of Intensive Care Medicine (ESICM) to complement the last IDSA/ATS guidelines published 3 years ago. Also supported by the Helics working group.
download    link to IDSA/ATS guidelines

Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis

Gilbert Habib (Chairperson); Bruno Hoen; Pilar Tornos; Franck Thuny; Bernard Prendergast; Isidre Vilacosta; Philippe Moreillon; Manuel de Jesus Antunes; Ulf Thilen; John Lekakis; Maria Lengyel; Ludwig Muller; Christoph K. Naber; Petros Nihoyannopoulos; Anton Moritz; Jose Luis Zamorano, EHJ 2009;30:2369-2413

download

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008

Dellinger RP, Mitchell ML, Carlet JM et al., Crit Care Med 2008 36: 296-327

download

Guidelines for the validation and application of typing methods for use in bacterial epidemiology

A. van Belkum et. al on behalf of the ESCMID Study Group on Epidemiological Markers (ESGEM), Clin Micro Biol Infect 2007: 13 (Suppl. 3): 1-46

download

Guidelines for the management of adult lower respiratory tract infections

M. Woodhead et al., Eur Respir J 2005 26: 1138-1180

download

Guidelines for the management of adult lower respiratory tract infections. Appendices

M. Woodhead et al.

download

Short statement of the first European consensus conference on the treatement of chronic hepatitis B and C in HIV Co-infected patients

A. Alberti et al., J Hepatol 2005 42: 615-624

download

European recommendations for antimicrobial resistance surveillance

G. Cornaglia et al., ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS), Clin Microbiol Infect 2004 10: 349-383

download

Guidelines for the diagnosis of tick-borne bacterial diseases in Europe

P. Brouqui et al., ESCMID Study Group on Coxiella, Anaplasma, Rickettsia and Bartonella (ESCAR) and the European Network for Surveillance of Tick-Borne Diseases, Clin Microbiol Infect 2004 10: 1108-1132

download

A European survey of diagnostic methods and testing protocols for Clostridium dificile

Barbut et al., ESCMID Study Group on Clostridium difficile (ESGCD), Clin Microbiol Infect 2003 9: 989-996

download

European Urinalysis Guidelines

T. Kouri et al., Scand J Clin Lab Invest 2000 60: 1-96

download

Last update: 23 August 2016

Do you need funding for guideline production?

Detailed guidance is provided in the ESCMID Operating Procedures for Medical Guidelines.

EOPs for Medical Guidelines